Delivery Order SPE2DB20D1100-SPE2DB25FB7Q8
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3010|SPE2DB25FP2HP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,555 units of the drug Vyvanse 40 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,969.48 and a completion date of May 1, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated....
This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,249,923 units of the prescription medication Vyvanse 40 mg capsules, with a ceiling value of $13,330.49. It has an ultimate completion date of April 10, 2024 and was awarded on April 9, 2024. The contract is a firm fixed-price delivery order and does not have a...
This federal contract award, with ID SPE2DB20D7061|SPE2DB25FSMV6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,641.78 firm fixed-price delivery order is for the supply of 4,567,909,420 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of 4,568,194,504 units of the prescription medication Vyvanse 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,048.31 and a period of performance through May 9, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWEW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,058,212 units of Vyvanse 40 mg capsules, with a ceiling value of $2,290.97. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp,...
This federal contract award, valued at $2,988.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB20D1100|SPE2DB25FB6B4) for the supply of 4,567,850,772 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,685.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,008,658 units of the prescription medication Vyvanse 40 mg capsules. The award is not designated as a set-aside contract, indicating open competition. It is a delivery order contract with a firm fixed-price pricing type, with an ultimate completion date...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,532.89, is a Firm Fixed Price Delivery Order for 4,568,531,470 units of the prescription medication Vyvanse 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 13, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award, valued at $2,454.20, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,552,082,418 units of the prescription drug Vyvanse 40 mg capsules. The contract has a ceiling value of $2,454.20 and a completion date of December 30, 2020. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used for this...
This federal contract award, with an award ID of SPE2DB22D3009|SPE2DB24FAT96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,960.58 firm fixed price delivery order is for the supply of 4,564,235,798 Vyvanse 40 mg capsules in 100-count bottles. The contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is also...